(ORTI-B) Ortivus ser. - Performance -50.8% in 12m
Compare ORTI-B with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-77.81%
#43 in Group
Rel. Strength
12.49%
#6963 in Universe
Total Return 12m
-50.79%
#33 in Group
Total Return 5y
-66.80%
#32 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -10.54%
19th Percentile in Group
12m Total Return: ORTI-B (-50.8%) vs XLV (-4.1%)
5y Drawdown (Underwater) Chart
Top Performers in Life Sciences Tools & Services
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| A NYSE Agilent Technologies |
9.48% | -23.3% | 38.3% | 24.9 | 19.3 | 1.76 | 60.8% | 7.8% |
| RVTY NYSE Revvity |
1.28% | -9.43% | 0.59% | 38.4 | 19.2 | 0.67 | -50.1% | -36.8% |
| QGEN NYSE Qiagen |
8.63% | -1.88% | -1.95% | 113 | 18.1 | 0.99 | -64.4% | -7.5% |
| SHC NASDAQ Sotera Health |
35% | 18% | -47.3% | 138 | 20.2 | 1.68 | -54.5% | -23.6% |
Performance Comparison: ORTI-B vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for ORTI-B
| Total Return (including Dividends) | ORTI-B | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -13.54% | 0.87% | 13.81% |
| 3 Months | -31.78% | -7.96% | -6.30% |
| 12 Months | -50.79% | -4.06% | 10.65% |
| 5 Years | -66.80% | 43.49% | 107.77% |
| Trend Score (consistency of price movement) | ORTI-B | XLV | S&P 500 |
| 1 Month | -79.3% | -8.1% | 83% |
| 3 Months | -64.8% | -75.3% | -75.3% |
| 12 Months | -70.0% | -28.8% | 50.1% |
| 5 Years | -72.3% | 89.7% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #43 | -14.3% | -24.0% |
| 3 Month | #24 | -25.9% | -27.2% |
| 12 Month | #33 | -48.7% | -55.5% |
| 5 Years | #32 | -76.9% | -84.0% |
FAQs
Does ORTI-B Ortivus ser. outperforms the market?
No,
over the last 12 months ORTI-B made -50.79%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.06%.
Over the last 3 months ORTI-B made -31.78%, while XLV made -7.96%.
Over the last 3 months ORTI-B made -31.78%, while XLV made -7.96%.
Performance Comparison ORTI-B vs Indeces and Sectors
ORTI-B vs. Indices ORTI-B is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -12.3% | -27.4% | -19.6% | -61.4% |
| US NASDAQ 100 | QQQ | -12.4% | -30.9% | -19.8% | -62.4% |
| US Dow Jones Industrial 30 | DIA | -12.7% | -23.5% | -19.3% | -58.5% |
| German DAX 40 | DAX | -12.2% | -28.5% | -45.9% | -76.5% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -14.4% | -25.4% | -20.4% | -58.2% |
| Hongkong Hang Seng | HSI | -15.4% | -33.5% | -28.0% | -64.5% |
| India NIFTY 50 | INDA | -7.33% | -18.4% | -20.1% | -50.6% |
| Brasil Bovespa | EWZ | -13.3% | -30.8% | -28.3% | -42.5% |
ORTI-B vs. Sectors ORTI-B is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -12.9% | -27.0% | -26.7% | -72.4% |
| Consumer Discretionary | XLY | -12.6% | -27.8% | -18.6% | -65.1% |
| Consumer Staples | XLP | -11.4% | -20.1% | -26.5% | -59.9% |
| Energy | XLE | -12.1% | -20.3% | -13.0% | -41.3% |
| Financial | XLF | -13.4% | -27.1% | -26.7% | -73.2% |
| Health Care | XLV | -9.24% | -14.4% | -14.6% | -46.7% |
| Industrial | XLI | -13.9% | -30.4% | -21.0% | -61.8% |
| Materials | XLB | -12.1% | -27.1% | -14.7% | -45.6% |
| Real Estate | XLRE | -10.9% | -25.1% | -20.4% | -66.2% |
| Technology | XLK | -13.3% | -34.8% | -16.7% | -57.9% |
| Utilities | XLU | -12.3% | -23.1% | -27.3% | -68.3% |
| Aerospace & Defense | XAR | -14.2% | -34.7% | -31.1% | -78.1% |
| Biotech | XBI | -5.66% | -25.4% | 0.53% | -38.5% |
| Homebuilder | XHB | -12.7% | -25.0% | -6.42% | -43.2% |
| Retail | XRT | -14.2% | -28.2% | -15.4% | -49.3% |